Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists

Pharmacology and Toxicology

Volumn 92, Issue 2, 2003, Pages 81-87

  Uhal, Bruce D ^a   Wang, Rongqi ^b   Laukka, Jeremy ^a   Zhuang, Jiaju ^a   Soledad Conrad, Valerie ^a   Filippatos, Gerasimos ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; CASPASE 3; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA FRAGMENT; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; LEUKOCYTE COUNT; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG FIBROSIS; LUNG TOXICITY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TOTAL LUNG CAPACITY;

AMIODARONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; APOPTOSIS; CAPTOPRIL; EPITHELIUM; LOSARTAN; LUNG; MALE; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0344990166     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920204.x     Document Type: Article

References (31)

1. Anonymous: Amiodarone and the thyroid: the Janus response. Lancet 1987, 2, 24-25.
2. Bargout, R., A. Jankov, E. Dincer, O. Ibarra-Sunga, T. Komodromos, G. Filippatos & B. D. Uhal: Amiodarone induces apoptosis in human and rat alveolar epithelial cells in vitro. Amer. J. Physiol. Lung 2000, 278, L1039-L1044.
3. Carvalho, C. R., R. Kairalla, V. Capellozi, M. Amato & P Saldiva: Chronic amiodarone ingestion induces pulmonary toxicity in rats. Braz. J. Med. Biol. Res. 1996, 29, 779-791.
4. Chuang, C. L., M. S. Chern & C. S. Chang: Amiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland and lung. Amer. J. Med. Sci. 2000, 320, 64-68.
5. Chung, W., B. Bennett, W. Racz, J. Brien & T Massey: Induction of c-jun and TGF-bl in Fischer 344 rats during amiodaroneinduced pulmonary fibrosis. Amer. J. Physiol. 2001, 281, L1180-Ll188.
6. Connolly, S. J.: Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999, 100, 2025-2034.
7. Dean, P. J., K. D. Groshart & J. G. Porterfield: Amiodarone associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Amer. J. Clin. Pathol. 1987, 87, 7-13.
8. Fraire, A. E., K. K. Guntupalli, D. Greenberg, J. Cartwright & M. H. Chasen: Amiodarone pulmonary toxicity: A multidisciplinary review of current status. South Med. J. 1993, 86, 67-77.
9. Greenspon, A. J., G. A. Kidwell, W. Hurley & J. Mannion: Amiodarone related postoperative adult respiratory distress syndrome. Circulation 1991, 84, Suppl III, III, 407-415.
10. Haschek, W. M. & H. P. Witschi. Pulmonary fibrosis: a possible mechanism. Toxicol. Appl. Pharmacol. 1979, 51, 475-487.
11. Kennedy, J., J. Myers, V. Plunb & J. Fulmer: Amiodarone pulmonary toxicity: clinical, radiologic and pathologic correlations. Arch. Intern. Med. 1987, 147, 50-56.
12. Kudenchuk, P. J., D. J. Pierson & H. L. Greene: Prospective evaluation of amiodarone pulmonary toxicity. Chest 1984, 86, 541-548.
13. Martino, E., L. Bartalena, F. Bogazzi & L. Braverman: The effects of amiodarone on the thyroid. Endocrinol. Rev. 2001, 22, 240-254.
14. Nalos, P. C., R. M. Kass, E. S. Gang, M. C. Fishbein, W. J. Mandel & T. Peter: Life-threatening post-operative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations. J. Thorac. Cardiovasc. Surg. 1987, 93, 904-912.
15. Neal Kay, G., A. E. Epstein, T. K. Kirklin, A. Diethelm, G. Graybar & V. Plumb: Fatal postoperative amiodarone pulmonary toxicity. Amer. J. Cardiol. 1988, 62, 490-492.
16. Ogle, C. & M. Reasor: Response of alveolar macrophages to amiodarone and desethylamiodarone in vitro. Toxicology 1990, 62, 227-238.
17. Ohar, J. A., F. Jackson, P. Dettenmeier, C. Bedrossian, S. Tricomi & R.G. Evans: Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992, 102, 999-1004.
18. Paine, R. & R. A. Simon: Expanding the frontiers of lung biology through the creative use of alveolar epithelial cells in culture. Amer. J. Physiol. 1996, 270, L484-L486.
19. Pick, R., J. Jalil, J. Janicki & K. Weber: The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Amen J. Pathol. 1989, 134, 365-371.
20. Piepoli, M., G. Villani, P. Ponikowski, A. Wright, M. Flather & A. Coats: Overview and meta-analysis of randomized trials of amiodarone in chronic heart failure. Int. J. Cardiol. 1998, 66, 1-10.
21. Reasor, M. & S. Kacew: An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity. Proc. Soc. Exp. Biol. Med. 1996, 212, 297-304.
22. Reasor, M. & S. Kacew: Drug-induced phospholipidosis: are there functional consequences? Proc. Soc. Exp. Biol. Med. 2001, 226, 825-830.
23. Reinhart, P. G. & C. G. Gairola: Amiodarone-induced pulmonary toxicity in Fischer rats: release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages. J. Toxicol. Environ. Health 1997, 52, 353-65.
24. Ruben, Z., S. N. Anderson & S. Kacew: Changes in saccharide and phospholipid content associated with drug storage in cultured rabbit aorta muscle cells. Lab. Invest. 1991, 64, 574-584.
25. Selman, M., T. E. King & A. Pardo: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001, 134, 136-151.
26. Singh, S., S. Fisher, P. Deedwania, P. Rohatgi, B. Singh & R. Fletcher: Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart FailureSurvival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). J. Amer. Coll. Cardiol. 1997, 30, 514-517.
27. Uhal, B. D.: Cell cycle kinetics in the alveolar epithelium (Invited Review). Amer. J. Physiol. 1997, 272, L1031-L1045.
28. Uhal, B. D., K. Flowers & D. E. Rannels: Type II pneumocyte proliferation in vitro: problems and future directions. Amer. J. Physiol. 1991, 261, Suppl. 110-117.
29. Wang, R., A. Zagariya, O. Ibarra-Sunga, C. Gidea, E. Ang, S. Deshmukh, G. Chaudhary, J. Baraboutis, G. Filippatos & B. D. Uhal: Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Amer. J. Physiol. 1999, 276, L885-L889.
30. Wang, R., O. Ibarra-Sunga, R. Pick & B. D. Uhal: Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Amer. J. Physiol. Lung 2000, 279, L143-L151.
31. Wilson, B. & M. Lippmann: Pulmonary accumulation of amiodarone and desethylamiodarone. Amer. Rev. Resp. Dis. 1990, 141, 1553-1558.